LAT staff has led a GCP FDA inspection at a site in Colombia. The inspection concluded with no findings (no FDA Form 483) issued.

LAT has great news to share! We have a new study in Bolivia. The recruitment is just starting for a new chemotherapy regimens and biomarkers for Chagas disease- TESEO

LAT has attended CPhI Worldwide on November 2019 and has strengthen it´s relationship with Clients, Vendors and providers. It has been a fruitful event and LAT will be sharing news on it´s outcome soon.

LAT has attended the BIO Latin America Conference held in Sao Paulo during September, during this event you will find high-level executives, industry leaders and policy makers to foster relationships. You can find LAT and its partner Azidus at the Innovation Arena, starting on September 3rd.

LAT attended the Congress held in Barranquilla for the Dynamic of Diseases transmitted via vectors. This Congress devoted special attention with key note speakers on Chagas, Dengue, Zika, Chikunguña and other diseases that have a high prevalence in our Region.

LAT attended the XIX International Symposium for Neglected Diseases, held in Buenos Aires during August. Important topics where discussed such as the TMI of Chagas, Syphilis, Leishmaniasis, HIV and Hepatitis B, and other aspects in relation to Neglected Diseases.